CureVac (CVAC) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

CVAC is expected to report earnings to fall 540.62% to $1.41 per share on November 14

Q3'24

Est.

$1.41

Q2'24

Missed

by $0.04

Q1'24

Est.

$-0.31

Q4'23

Missed

by $0.20

Q3'23

Est.

$-0.22

The last earnings report on August 15 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 273.98K shares outstanding, the current market capitalization sits at 672.94M.

View a ticker or compare two or three

Compare

CVAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CVAC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Friedrich-Miescher-Strasse 15

Phone

+49 707198830

Employees

1049

Web

https://www.curevac.com